Business Segment and Geographic Data (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues		$ 7,258	$ 3,539	$ 29,734
Costs of revenues		1,487	100	7,595
Gross profit		$ 5,771	$ 3,439	$ 22,139
Gross profit %		79.50%	97.10%	74.50%
Allocated operating expenses:
Engineering and product development		$ 326	$ 143	$ 983
Selling and marketing expenses		4,529	620	18,757
Impairment		3,518		3,518
Loss on sale of assets	594	1,731	4,845	2,574
Unallocated operating expense	2,888	2,894	4,428	9,791
Total	3,482	12,998	10,036	35,623
Income (loss) from continuing operations	(3,482)	(7,227)	(6,597)	(13,484)
Revaluation of asset contribution related financial instruments, net	326		2,948
Interest and other financing income (expense), net	20	88	(103)	(537)
Income (loss) from continuing operations before income taxes	(3,136)	(7,139)	(3,752)	(14,021)
CONSUMER [Member]
Revenues		6,142	3,539	25,724
Costs of revenues		909	100	5,412
Gross profit		$ 5,233	$ 3,439	$ 20,312
Gross profit %		85.20%	97.10%	79.00%
Allocated operating expenses:
Engineering and product development		$ 243	$ 143	$ 779
Selling and marketing expenses		3,921	620	16,677
Impairment		3,518		3,518
Loss on sale of assets	594		4,816
Unallocated operating expense
Total	594	7,682	5,579	20,974
Income (loss) from continuing operations	(594)	(2,449)	(2,140)	(662)
Revaluation of asset contribution related financial instruments, net
Interest and other financing income (expense), net
Income (loss) from continuing operations before income taxes	(594)	(2,449)	(2,140)	(662)
PHYSICIAN RECURRING [Member]
Revenues		840		3,302
Costs of revenues		461		1,853
Gross profit		$ 379		$ 1,449
Gross profit %		45.10%		43.90%
Allocated operating expenses:
Engineering and product development		$ 83		$ 204
Selling and marketing expenses		591		2,045
Loss on sale of assets		1,731	29	1,731
Unallocated operating expense
Total		2,405	29	3,980
Income (loss) from continuing operations		(2,026)	(29)	(2,531)
Revaluation of asset contribution related financial instruments, net
Interest and other financing income (expense), net
Income (loss) from continuing operations before income taxes		(2,026)	(29)	(2,531)
PROFESSIONAL [Member]
Revenues		276		708
Costs of revenues		117		330
Gross profit		$ 159		$ 378
Gross profit %		57.60%		53.40%
Allocated operating expenses:
Engineering and product development
Selling and marketing expenses		17		35
Loss on sale of assets				843
Unallocated operating expense
Total		17		878
Income (loss) from continuing operations		142		(500)
Revaluation of asset contribution related financial instruments, net
Interest and other financing income (expense), net
Income (loss) from continuing operations before income taxes		$ 142		$ (500)